SCN5A and hereditary sensory and autonomic neuropathy: To mimic the genetic loss-of-function mechanism in congenital insensitivity to pain (CIP) patients, an ideal Nav1.7 inhibitor should have sufficient selectivity against both Nav1.2 and Nav1.5 and should display greater state-independent inhibition.